On this page you will find our recommendations sorted by BNF chapter.
Appraisal Reports are available to stakeholders on request.
Where a decision is >24 months old; these are highlighted in red. If you are a clinician working within the NTAG region and would like to prioritise an old decision for re-review please contact the professional secretary on firstname.lastname@example.org
|Left atrial appendage occlusion devices for stroke prevention in patients with non-valvular atrial fibrillation (NETAG)||Recommendation||Recommended for patients with a proven bleeding risk which contraindicates anticoagulation therapy||10/07/2012|
|Stand-alone minimally invasive bipolar radiofrequency ablation for Atrial Fibrillation (NETAG)||Recommendation||Recommended for atrial fibrillation where catheter ablation is not suitable due to clinical, technical or anatomical reasons||12/07/2011|
|Top Tips and Recommendations for Sodium Glucose Co-transporter 2 inhibitors (SGLT2i) in HFrEF||SGLT2 in Heart Failure Top Tips NTAG v1 - approved June 2022||Approved by NTAG||07/06/2022|
|NENC Patient Specific Factors to Consider When Choosing a DOAC in NVAF||NENC Decision Aid incl Table to support decison of DOAC in AF - approved June 2022 - final||Approved by NTAG||07/06/2022|
|Northern England Evaluation and Lipid Intensification guideline||NEELI edit v2022.2-FINAL-NTAG||Approved by NTAG||06/09/2022|